Deutsche Bank AG Trims Holdings in Indivior PLC $INDV

Deutsche Bank AG cut its position in shares of Indivior PLC (NASDAQ:INDV) by 7.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 266,977 shares of the company’s stock after selling 21,496 shares during the quarter. Deutsche Bank AG owned 0.19% of Indivior worth $2,544,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in INDV. D. E. Shaw & Co. Inc. acquired a new stake in Indivior in the fourth quarter worth $1,238,000. Melqart Asset Management UK Ltd increased its position in Indivior by 675.6% in the fourth quarter. Melqart Asset Management UK Ltd now owns 104,790 shares of the company’s stock worth $1,303,000 after buying an additional 91,280 shares during the period. Jane Street Group LLC increased its position in Indivior by 101.9% in the fourth quarter. Jane Street Group LLC now owns 36,881 shares of the company’s stock worth $473,000 after buying an additional 18,611 shares during the period. Foursixthree Capital LP acquired a new stake in Indivior in the fourth quarter worth $4,639,000. Finally, Schonfeld Strategic Advisors LLC acquired a new stake in Indivior in the fourth quarter worth $1,686,000. 60.33% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

INDV has been the topic of a number of recent analyst reports. HC Wainwright initiated coverage on shares of Indivior in a research note on Wednesday, August 6th. They set a “buy” rating and a $27.00 price objective on the stock. Jefferies Financial Group assumed coverage on Indivior in a research report on Tuesday, July 22nd. They set a “buy” rating and a $20.00 price objective for the company. Wall Street Zen upgraded Indivior from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 21st. Finally, Craig Hallum boosted their price target on Indivior from $15.00 to $22.00 and gave the company a “buy” rating in a research note on Monday, June 30th. One investment analyst has rated the stock with a Strong Buy rating and five have issued a Buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $19.60.

Indivior Trading Up 0.3%

INDV stock opened at $23.48 on Wednesday. The business’s fifty day moving average price is $17.19 and its two-hundred day moving average price is $12.78. Indivior PLC has a fifty-two week low of $7.33 and a fifty-two week high of $23.84.

Indivior (NASDAQ:INDV) last announced its quarterly earnings data on Thursday, July 31st. The company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.25. The firm had revenue of $302.00 million during the quarter, compared to analysts’ expectations of $239.43 million. Indivior had a negative return on equity of 86.28% and a net margin of 6.65%. Indivior has set its FY 2025 guidance at EPS. Equities analysts predict that Indivior PLC will post 1.22 EPS for the current fiscal year.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.